Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager

por Xiao, Xinghui, Cheng, Ying, Zheng, Xiaodong, Fang, Yuhang, Zhang, Yu, Sun, Rui, Tian, Zhigang, Sun, Haoyu
Publicado 2023

Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer

por Fang, Yuhang, Sun, Haoyu, Xiao, Xinghui, Tang, Maoxing, Tian, Zhigang, Wei, Haiming, Sun, Rui, Zheng, Xiaodong
Publicado 2022